Sale!

ATP8B1 Gene Cholestasis benign recurrent intrahepatic Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The ATP8B1 gene plays a significant role in the normal functioning of the liver, and mutations in this gene can lead to a condition known as benign recurrent intraheptic cholestasis (BRIC). BRIC is characterized by episodes of liver dysfunction that can cause jaundice, itching, and elevated liver enzymes, but typically does not lead to long-term liver damage. Genetic testing for mutations in the ATP8B1 gene can provide crucial information for diagnosing this condition, guiding treatment options, and offering insights into the prognosis.

At DNA Labs UAE, a specialized genetic test is available for identifying mutations in the ATP8B1 gene that are associated with benign recurrent intraheptic cholestasis. The test is conducted using a blood sample, with results typically available within a few weeks. The cost of the test is 3200 AED. This testing can be particularly valuable for individuals who have experienced symptoms suggestive of BRIC, or for family members of individuals diagnosed with the condition, as it can help in understanding the genetic basis of the disease and in making informed decisions about management and monitoring.

Description

ATP8B1 Gene Cholestasis Benign Recurrent Intrahepatic Genetic Test

Test Name: ATP8B1 Gene Cholestasis Benign Recurrent Intrahepatic Genetic Test

Components: ATP8B1 gene cholestasis, NGS technology

Price: 3200.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ATP8B1 Gene Cholestasis, benign recurrent intrahepatic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Cholestasis, benign recurrent intrahepatic.

Test Details:

ATP8B1 gene cholestasis, also known as benign recurrent intrahepatic cholestasis type 1 (BRIC1), is a rare genetic disorder that affects the liver’s ability to transport bile acids. This results in the accumulation of bile acids in the liver, leading to episodes of cholestasis (impaired bile flow) and subsequent liver damage.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of ATP8B1 gene cholestasis, NGS genetic testing can be used to identify mutations or variants in the ATP8B1 gene that are associated with the condition.

NGS genetic testing for ATP8B1 gene cholestasis involves obtaining a DNA sample, typically through a blood sample, from the individual suspected of having the condition. The DNA sample is then sequenced using NGS technology to analyze the ATP8B1 gene for any disease-causing mutations or variants.

The results of the NGS genetic test can help confirm a diagnosis of ATP8B1 gene cholestasis and provide information about the specific genetic variant(s) present in the individual. This information can be valuable for genetic counseling, family planning, and potentially guiding treatment decisions.

It is important to note that NGS genetic testing may not be available in all healthcare settings and can be costly. Therefore, it is typically recommended for individuals with a strong clinical suspicion of ATP8B1 gene cholestasis or for those with a family history of the condition. A healthcare professional, such as a geneticist or genetic counselor, can provide guidance on whether NGS genetic testing is appropriate in a given situation.

Test Name	ATP8B1 Gene Cholestasis benign recurrent intrahepatic Genetic Test
Components
Price	3200.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ATP8B1 Gene Cholestasis, benign recurrent intrahepatic NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Cholestasis, benign recurrent intrahepatic
Test Details	ATP8B1 gene cholestasis, also known as benign recurrent intrahepatic cholestasis type 1 (BRIC1), is a rare genetic disorder that affects the liver’s ability to transport bile acids. This results in the accumulation of bile acids in the liver, leading to episodes of cholestasis (impaired bile flow) and subsequent liver damage. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of ATP8B1 gene cholestasis, NGS genetic testing can be used to identify mutations or variants in the ATP8B1 gene that are associated with the condition. NGS genetic testing for ATP8B1 gene cholestasis involves obtaining a DNA sample, typically through a blood sample, from the individual suspected of having the condition. The DNA sample is then sequenced using NGS technology to analyze the ATP8B1 gene for any disease-causing mutations or variants. The results of the NGS genetic test can help confirm a diagnosis of ATP8B1 gene cholestasis and provide information about the specific genetic variant(s) present in the individual. This information can be valuable for genetic counseling, family planning, and potentially guiding treatment decisions. It is important to note that NGS genetic testing may not be available in all healthcare settings and can be costly. Therefore, it is typically recommended for individuals with a strong clinical suspicion of ATP8B1 gene cholestasis or for those with a family history of the condition. A healthcare professional, such as a geneticist or genetic counselor, can provide guidance on whether NGS genetic testing is appropriate in a given situation.